This study is looking at whether giving DHA (docosahexaenoic acid), a type of healthy fat, early to very preterm infants (babies born very early) who are also growth-restricted (smaller than expected for their age) can help them grow better. These babies often have low levels of DHA and fat, which can affect their growth. Researchers want to see if early DHA supplementation can lead to a bigger head circumference (a measure of head growth) without affecting how much fat they gain. To join, infants must be between 24 and 72 hours old, born between 22 and 32 weeks of pregnancy, and have a birth weight less than the 25th percentile. The main goal is to measure head circumference when the baby reaches 36 weeks postmenstrual age (their age from the start of the mother's last period) or when they are discharged from the hospital. The current recruitment status is unclear.

Study design

This is an interventional study planning to enroll 152 participants. It is a randomized clinical trial, meaning participants will be assigned by chance to receive either DHA supplementation or standard care.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed until they reach 36 weeks postmenstrual age or are discharged from the hospital.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.